Nugen Medical Devices Stock Performance
| NGMDF Stock | USD 0.03 0.00 0.00% |
The company secures a Beta (Market Risk) of -0.21, which conveys not very significant fluctuations relative to the market. As returns on the market increase, returns on owning NuGen Medical are expected to decrease at a much lower rate. During the bear market, NuGen Medical is likely to outperform the market. At this point, NuGen Medical Devices has a negative expected return of -0.6%. Please make sure to verify NuGen Medical's information ratio and the relationship between the value at risk and relative strength index , to decide if NuGen Medical Devices performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days NuGen Medical Devices has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's fundamental indicators remain nearly stable which may send shares a bit higher in January 2026. The current disturbance may also be a sign of long-run up-swing for the company stockholders. ...more
NuGen |
NuGen Medical Relative Risk vs. Return Landscape
If you would invest 3.99 in NuGen Medical Devices on October 2, 2025 and sell it today you would lose (1.49) from holding NuGen Medical Devices or give up 37.34% of portfolio value over 90 days. NuGen Medical Devices is currently producing negative expected returns and takes up 4.8989% volatility of returns over 90 trading days. Put another way, 43% of traded otc stocks are less volatile than NuGen, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
NuGen Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for NuGen Medical's investment risk. Standard deviation is the most common way to measure market volatility of otc stocks, such as NuGen Medical Devices, and traders can use it to determine the average amount a NuGen Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1235
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | NGMDF |
Based on monthly moving average NuGen Medical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of NuGen Medical by adding NuGen Medical to a well-diversified portfolio.
NuGen Medical Fundamentals Growth
NuGen OTC Stock prices reflect investors' perceptions of the future prospects and financial health of NuGen Medical, and NuGen Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on NuGen OTC Stock performance.
| Return On Equity | -14.72 | |||
| Return On Asset | -0.42 | |||
| Operating Margin | (29.06) % | |||
| Current Valuation | 7.67 M | |||
| Shares Outstanding | 96.56 M | |||
| Price To Book | 9.94 X | |||
| Price To Sales | 13.04 X | |||
| Revenue | 137.65 K | |||
| EBITDA | (5.09 M) | |||
| Cash And Equivalents | 87.48 K | |||
| Total Debt | 5.61 M | |||
| Debt To Equity | 7.40 % | |||
| Book Value Per Share | (0.01) X | |||
| Cash Flow From Operations | (4.1 M) | |||
| Earnings Per Share | (0.08) X | |||
| Total Asset | 8.84 M | |||
About NuGen Medical Performance
By analyzing NuGen Medical's fundamental ratios, stakeholders can gain valuable insights into NuGen Medical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if NuGen Medical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if NuGen Medical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
NuGen Medical Devices Inc., a specialty medical device company, focuses on developing and commercializing novel drug delivery technologies. It offers needle-free injection devices and systems for the administration of subcutaneous medication for various fields, including anaphylaxis, diabetes, severe migraine, erectile dysfunction, chronic anemia, neutropenia, autoimmune rheumatoid arthritis, growth and fertility hormone, and psoriasis, as well as DNA and conventionalpediatric vaccines. Nugen Med operates under Medical Devices classification in the United States and is traded on OTC Exchange.Things to note about NuGen Medical Devices performance evaluation
Checking the ongoing alerts about NuGen Medical for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for NuGen Medical Devices help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| NuGen Medical generated a negative expected return over the last 90 days | |
| NuGen Medical has some characteristics of a very speculative penny stock | |
| NuGen Medical has high historical volatility and very poor performance | |
| NuGen Medical has high likelihood to experience some financial distress in the next 2 years | |
| NuGen Medical Devices has accumulated 5.61 M in total debt with debt to equity ratio (D/E) of 7.4, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. NuGen Medical Devices has a current ratio of 0.44, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist NuGen Medical until it has trouble settling it off, either with new capital or with free cash flow. So, NuGen Medical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like NuGen Medical Devices sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for NuGen to invest in growth at high rates of return. When we think about NuGen Medical's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the revenue of 137.65 K. Net Loss for the year was (7.11 M) with profit before overhead, payroll, taxes, and interest of 47.3 K. | |
| NuGen Medical Devices has accumulated about 87.48 K in cash with (4.1 M) of positive cash flow from operations. | |
| Roughly 19.0% of NuGen Medical outstanding shares are owned by corporate insiders |
- Analyzing NuGen Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether NuGen Medical's stock is overvalued or undervalued compared to its peers.
- Examining NuGen Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating NuGen Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of NuGen Medical's management team can help you assess the OTC Stock's leadership.
- Pay attention to analyst opinions and ratings of NuGen Medical's otc stock. These opinions can provide insight into NuGen Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for NuGen OTC Stock analysis
When running NuGen Medical's price analysis, check to measure NuGen Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NuGen Medical is operating at the current time. Most of NuGen Medical's value examination focuses on studying past and present price action to predict the probability of NuGen Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NuGen Medical's price. Additionally, you may evaluate how the addition of NuGen Medical to your portfolios can decrease your overall portfolio volatility.
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |